|
 |
cyclobenzaprine HCLThis page contains recent news articles, when available, and an overview of cyclobenzaprine HCL but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: cyclobenzaprine HCL (when available) Cyclobenzaprine, closely related to the antidepressant amitriptyline, is used as a skeletal muscle relaxant to reduce pain and tenderness to and improve mobility. Unlike dantrolene, cyclobenzaprine cannot be used to treat muscle spasm secondary to cerebral or spinal cord disease. For use as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions Mechanism Of Action: Like the tricyclic antidepressants, cyclobenzaprine exhibits anticholinergic activity, potentiation of norepinephrine, and antagonism of reserpine. Cyclobenzaprine does not directly act on the neuromuscular junction or the muscle but relieves muscle spasms through a central action, possibly at the brain stem level. Cyclobenzaprine binds to the serotonin receptor and is considered a 5-HT2 receptor antagonist that reduces muscle tone by decreasing the activity of descending serotonergic neurons. News Articles on Cyclobenzaprine Eurand Reports Recent Developments and Second Quarter 2008 ... - 07 Aug 2008 In another noteworthy development, the Company was granted a patent for Amrix(r) (cyclobenzaprine HCl), the first and only once-daily skeletal muscle MarketWatch Eurand Enters Agreement With Daewoong Pharmaceutical Co. Ltd ... - Aug 1, 2008 Cyclobenzaprine HCl is a centrally acting muscle relaxant indicated as an adjunct to rest for the relief of muscle spasm associated with acute, FOXBusiness Market Report -- In Play (EURX) - Aug 1, 2008 ...subject to regulatory approval, Eurand's novel extended-release formulation of the muscle relaxant Cyclobenzaprine HCl in South Korea. MSN Money Eurand to Be Issued US Patent for Amrix(r) - Jun 3, 2008 According to IMS, Cyclobenzaprine HCl is the most widely prescribed muscle relaxant in the US, representing 37 percent of the 45 million prescriptions FOXBusiness India Ranbaxy gets FDA nod for cyclobenzaprine HCL - May 14, 2008 MUMBAI, May 15 (Reuters) - Indian drugmaker Ranbaxy Laboratories Ltd (RANB.BO: Quote, Profile, Research) has received approval from the US Food and Drug Reuters India, Ranbaxy gets USFDA nod for sale of Cyclobenzaprine HCL Tablets in US - May 16, 2008 Cyclobenzaprine HCl Tablets USP are indicated as adjuncts to rest and physical therapy for relief of muscle spasm associated with acute, TopNews, Ranbaxy gets US FDA approval for cyclobenzaprine HCL - May 15, 2008 Ranbaxy Laboratories has received approval from the US Food and Drug Administration for muscle relaxant cyclobenzaprine hydrochloride tablets. Myiris.com, Amneal Pharmaceuticals Receives US FDA Approval for Three Generic ... - May 7, 2008 Cyclobenzaprine HCl Tablets USP, in 10mg strength, is an AB-Rated therapeutically equivalent alternative to FLEXERIL(R) (a trademark of McNeil Consumer FOXBusiness Eurand Reports First Quarter 2008 Key Achievements and Financial ... - May 9, 2008 Eurand also provided an update on Amrix(r) (cyclobenzaprine HCl), the only once-daily skeletal muscle relaxant which Eurand developed that is currently Primenewswire (press release), Eurand Reports First Quarter 2008 Key Achievements and Financial ... - May 9, 2008 Eurand also provided an update on Amrix(r) (cyclobenzaprine HCl), the only once-daily skeletal muscle relaxant which Eurand developed that is currently Therapeutics Daily (subscription) (press release), Eurand Receives a Notice of Allowance for US Patent Application ... - Apr 9, 2008 According to IMS, Cyclobenzaprine HCl is the most widely prescribed muscle relaxant in the US, representing 37 percent of the 45 million prescriptions Primenewswire (press release), DJ HUGIN NEWS/Eurand Reports Fourth Quarter and Year-end 2007 Key ... - Mar 6, 2008 Eurand also provided an update on Amrix(r) (cyclobenzaprine HCl), the only once-daily skeletal muscle relaxant which Eurand developed that is currently VisAvis (Pressemitteilung), Eurand Reports Third Quarter 2007 Key Achievements and Financial ... - Nov 9, 2007 Two important highlights included the acquisition by Cephalon of Amrix(r) (cyclobenzaprine hcl), a product we co-developed, from ECR Pharmaceuticals and the CNNMoney.com Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily ... - Aug 23, 2007 ..."Cyclobenzaprine HCl is the most widely prescribed muscle relaxant in the United States, representing 37 percent of the 45 million prescriptions for muscle CNNMoney.com [an error occurred while processing this directive] [an error occurred while processing this directive] Brand Names/Synonyms: cyclobenzaprine HCL is also known by the following brand names and/or synonymsCyclobenz; Cyclobenzaprine; Cyclobenzaprine Hcl; Flexeril; Flexiban; MK-130; Proeptatriene; Proheptatriene; RP-9715 Drug Category: cyclobenzaprine HCL is categorized under the following by the FDA: Tranquilizing Agents; Muscle Relaxants; Antidepressants; Skeletal Muscle Relaxants; ATC:M03BX08 Dosage Forms: D-shaped, film coated tablets Absorption: Well absorbed after oral administration Interactions: -->Interactions for Cyclobenzaprine: FLEXERIL may have life-threatening interactions with MAO inhibitors. FLEXERIL may enhance the effects of alcohol, barbiturates, and other CNS depressants. Tricyclic antidepressants may block the antihypertensive action of guanethidine and similarly acting compounds. Tricyclic antidepressants may enhance the seizure risk in patients taking tramadol. |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |